Mental Health and Suicidality in Glioblastoma Patients in Germany
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The aim of the study is to use standardized questionnaires to systematically record influencing factors or predictors for suicidal behavior in glioblastoma patients, particularly with regard to existing depression and anxiety symptoms.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Nowo rozpoznany glejiak mózgu (typ IDH wild-type)
- •Zakończona radioterapia (przed pierwszym nawrotem choroby)
- •Wiek 18 lat lub więcej
✗ Disqualifies
- •Poważne problemy z mową lub język obcy jako bariera komunikacji
- •Historia innych nowotworów złośliwych
- •Dziedziczna predyspozycja do nowotworów (np. zespół Li-Fraumeni)
- •Nawrotowy glejiak mózgu
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- August 27, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (6)
Charite
Berlin, Germany
University Hospital Knappschaftskrankenhaus Bochum
Bochum, Germany
University Hospital Essen
Essen, Germany
University hospital Hamburg Eppendorf
Hamburg, Germany
University hospital Heidelberg
Heidelberg, Germany
University hospital Muenster
Münster, Germany
Trial contact
Christoph Oster, Dr. med.
Mareike Rutenkröger, Dr. rer. medic.
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 8/28/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.